Dr. Jerian is an expert in hematology and oncology with over 27 years of experience on clinical development and regulatory affairs in the Pharmaceutical/Biotechnology Industry and the Food and Drug Administration (FDA) with a track record of product approvals (over 20) and successful clinical programs. Her areas of focus are: strategic oncology product development including drugs, biologics (antibodies, therapeutic proteins, tumor vaccines, cellular and gene therapies), and devices (stem cell selection devices and in vitro diagnostics), clinical trial design and regulatory strategy for all phases of product development.
Since 2006, she has been President of ONCORD, Inc. providing regulatory and clinical development consulting in oncology. Prior to consulting, she served as a Supervisory Medical Officer at the Food and Drug Administration (FDA), Center for Biologics Evaluation and Research (CBER; 1995-2003) and Global Medical Director at Amgen Inc. (2003-2005). At FDA, she led a team of oncologists conducting clinical regulatory reviews and oversight for a portfolio of hundreds of INDs as well as multiple license applications and supplements for multiple product classes. She was the primary clinical reviewer for over a hundred INDs and multiple license applications and supplements.
Susan holds a BS from Occidental College, an MD from George Washington University, conducted her residency in Internal Medicine at the University of Arizona, Tucson and was a fellow in Medical Oncology at the National Cancer Institute in Bethesda.